An RNA-to-RNA pipeline for rapid antiviral antibody development.

Saved in:
Bibliographic Details
Title: An RNA-to-RNA pipeline for rapid antiviral antibody development.
Authors: Hodge EA; HDT Bio, Seattle, WA 98109, USA., Archer J; HDT Bio, Seattle, WA 98109, USA., Anderson JS; Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA., Warner NL; HDT Bio, Seattle, WA 98109, USA., Tremblay J; Department of Infectious Disease and Global Health, Tufts University, North Grafton, MA 01536, USA., Klose T; Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA., Park S; HDT Bio, Seattle, WA 98109, USA., Hinkley T; HDT Bio, Seattle, WA 98109, USA., Khandhar AP; HDT Bio, Seattle, WA 98109, USA., Kuhn R; Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA., Shoemaker CB; Department of Infectious Disease and Global Health, Tufts University, North Grafton, MA 01536, USA., Erasmus JH; HDT Bio, Seattle, WA 98109, USA. Electronic address: jesse.erasmus@hdt.bio.
Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Jul 01; Vol. 34 (7), pp. 4136-4152. Date of Electronic Publication: 2026 Apr 09.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1525-0024
DOI:10.1016/j.ymthe.2026.04.021